Stock Price
25.38
Daily Change
0.12 0.48%
Monthly
2.26%
Yearly
60.94%
Q3 Forecast
25.05

Acadia Pharmaceuticals reported $20.1M in Trade Creditors for its fiscal quarter ending in June of 2025.




Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
ALKERMES USD 99.21M 39.37M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical USD 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Corcept Therapeutics USD 23.52M 4.42M Jun/2025
Cytokinetics USD 68.54M 54.6M Jun/2025
Eisai JPY 82.98B 8.59B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
J&J USD 9.54B 766M Mar/2025
Moderna USD 175M 51M Jun/2025
Neurocrine Biosciences USD 104.6M 5.4M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Prothena USD 12.2M 4.43M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025